Literature DB >> 16923692

Preeclampsia: Diagnosis and management of the atypical presentation.

Caroline L Stella1, Baha M Sibai.   

Abstract

Preeclampsia, eclampsia, and HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome remain as major obstetric problems that plague a large percentage of women resulting in an equally large percentage of maternal and perinatal morbidities. It is important that a clinician makes the most accurate diagnosis possible to prevent these adverse maternal and perinatal outcomes. In general, most women will have a classical presentation of preeclampsia (hypertension and proteinuria) at >20 weeks gestation and <48 hours postpartum. However, recent studies have suggested that some women will develop preeclampsia without the classical findings. The purpose of this review is to increase awareness of the non-classical and atypical features of preeclampsia, eclampsia, and HELLP syndrome and their respective management. Atypical cases are those that develop before 20 weeks, beyond 48 hours postpartum and those that present with some of the signs and symptoms of preeclampsia without the usual hypertension or proteinuria. By formulating a rational stepwise approach towards diagnosis, we may prevent the costly consequence of a missed diagnosis and its eventual possible fatalities.

Entities:  

Mesh:

Year:  2006        PMID: 16923692     DOI: 10.1080/14767050600678337

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  13 in total

1.  MiR-616-3p modulates cell proliferation and migration through targeting tissue factor pathway inhibitor 2 in preeclampsia.

Authors:  Yetao Xu; Dan Wu; Ziyan Jiang; Yuanyuan Zhang; Sailan Wang; Zhonghua Ma; Bingqing Hui; Jing Wang; Weiping Qian; Zhiping Ge; Lizhou Sun
Journal:  Cell Prolif       Date:  2018-07-20       Impact factor: 6.831

2.  Effects of sildenafil on maternal hemodynamics and fetal growth in normal rat pregnancy.

Authors:  Jennifer M Sasser; Chris Baylis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-02       Impact factor: 3.619

3.  The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome.

Authors:  Brett Young; Richard J Levine; Saira Salahuddin; Cong Qian; Kee-Hak Lim; S Ananth Karumanchi; Sarosh Rana
Journal:  J Matern Fetal Neonatal Med       Date:  2010-05

4.  Intracranial Tuberculoma Presenting as Atypical Eclampsia: A Case Report.

Authors:  Sendhil Coumary Arumugam; Sharmila Murugesan; Sunitha Pradeep; Lopamudra John; Vasavi Kolluru
Journal:  J Clin Diagn Res       Date:  2016-06-01

Review 5.  Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature.

Authors:  A K Chow; J Cena; R Schulz
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

6.  Atypical preeclampsia and eclampsia: report of four cases and review of the literature.

Authors:  Mustafa Albayrak; Ismail Ozdemir; Yavuz Demiraran; Süber Dikici
Journal:  J Turk Ger Gynecol Assoc       Date:  2010-06-01

7.  Altered global gene expression in first trimester placentas of women destined to develop preeclampsia.

Authors:  S A Founds; Y P Conley; J F Lyons-Weiler; A Jeyabalan; W Allen Hogge; K P Conrad
Journal:  Placenta       Date:  2008-11-21       Impact factor: 3.481

8.  Wound haematoma: The first sign in a case of late postpartum HELLP syndrome.

Authors:  Natasha Louise Pritchard; Jodi Leanne Keane
Journal:  Case Rep Womens Health       Date:  2015-08-22

9.  Transient diabetes insipidus in a post-partum woman with pre-eclampsia associated with residual placental vasopressinase activity.

Authors:  Natassia Rodrigo; Samantha Hocking
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-05-21

10.  Atypical preeclampsia - Gestational proteinuria.

Authors:  Amy B Stevens; Diane M Brasuell; Rebecca N Higdon
Journal:  J Family Med Prim Care       Date:  2017 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.